Artificial intelligence is no longer an abstract concept in medicine.

It is already changing the way doctors treat patients and diagnose disease. Meanwhile, drug companies are using it to develop new cures and mine huge stores of patient data to hone treatments and improve clinical trials.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Hello…do you by any chance offer discounts for the unemployed? I have been unemployed since April…I am looking to make a career change into healthcare IT…I am 61 yrs old and it’s an uphill battle at best…your publication would be useful to me in my job search…thank you for your time…regards Barry

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy